课题基金 / 基金详情

Function of the BTB/POZ domain transcription factor Miz-1 in the activation of lymphoid cells and in lymphoid leukemia and lymphoma

Function of the BTB/POZ domain transcription factor Miz-1 in the activation of lymphoid cells and in lymphoid leukemia and lymphoma
BTB/POZ 结构域转录因子 Miz-1 在淋巴细胞活化以及淋巴白血病和淋巴瘤中的功能
批准号：
224822
负责人：
Moroy Tarik
金额：
$51.47万
依托单位：
Institut de recherches cliniques de Montral
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-03-01 至 2016-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=224822&lang=en
关键词：
Hematopoiesis Lymphocyte Activation Lymphocyte Maturation Malignant Transformation Signal Transduction Transcription Factors Transgenic And Knockout Mouse Models

项目摘要

项目成果

Moroy Tarik的其他基金

相似基金

相关文献

中文摘要
翻译
淋巴瘤和白血病都是血细胞、血细胞前体甚至是血液干细胞的癌症，这些细胞被编程形成血细胞。淋巴瘤是指位于淋巴结、脾或胸腺的实体肿块，而白血病的特征是
英文摘要
Lymphoma and leukemia are both cancers of blood cells, blood cell precursors or even blood stem cells that are programmed to form blood cells. While a lymphoma is present as a solid tumor mass in lymph nodes, spleen or thymus, leukemia is characterized by
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The MYC/MIZ-1 complex in germinal center B cells and B cell lymphomagenesis
Therapeutic potential of the long non-coding RNA ELDR for the Acute Myeloid Leukemia subtype M5 with t(9;11) translocations
The role of the RNA helicase DDX3X in Burkitt Lymphoma and its potential as a new therapeutic target
Transcriptional control of hematopoiesis, immune cell differentiation and leukemia
海外基金